Skip to main content

Diabetes Mellitus News (Page 4)

Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says

TUESDAY, Aug. 29, 2023 – The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies. The list...

Adult Interpersonal Violence or Childhood Abuse, Neglect Increase Later Diabetes Risk

FRIDAY, Aug. 25, 2023 – Both adult interpersonal violence or abuse and childhood abuse or neglect increase the risk for adult-onset diabetes, according to a study recently published in the American...

EASD: Factors Linked to Lower-Limb Amputation ID'd in Diabetes

WEDNESDAY, Aug. 23, 2023 – For people with newly diagnosed diabetes, the risk for lower-limb amputation (LLA) is increased for those with older age, males, and divorced individuals, according to a...

Ultraprocessed Food Increases Risk for Death With Type 2 Diabetes

WEDNESDAY, Aug. 2, 2023 – Higher consumption of ultraprocessed food (UPF) is associated with lower survival and higher cardiovascular mortality in patients with type 2 diabetes, according to a study...

Here's How to Make Summer Sports Camp a Safe Adventure for Your Kid

WEDNESDAY, July 19, 2023 – If your child is in sports camp this summer, you’ll want them to have fun and stay safe. The National Athletic Trainers’ Association (NATA) offers some tips on dealing wit...

Discordance Seen in Self-Reported, Actual Comorbidities in Native American Adults

TUESDAY, July 18, 2023 – There is discordance between the prevalence of self-reported comorbidities and measured cardiometabolic risk factors among Native American adults, according to a study...

Incidence of Childhood Diabetes Up Globally

THURSDAY, July 13, 2023 – Childhood diabetes is an increasing global health challenge, according to a study published online July 3 in JAMA Pediatrics. Kexin Zhang, from Affiliated Hospital of...

Loneliness, but Not Social Isolation, Tied to CVD Risk With Diabetes

MONDAY, July 3, 2023 – Loneliness is associated with a higher risk for cardiovascular disease (CVD) in patients with diabetes, according to a study published online June 29 in the European Heart...

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

July 24, 2019 – The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be...

Baxter Announces U.S FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion

DEERFIELD, Ill. - July 22, 2019 Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA)...

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

 3 May 2019 – The US Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to ...

FDA Medwatch Alert: Caution When Using Pen Needles to Inject Medicines: FDA Safety Communication

Audience: Patients and caregivers who use or are considering using pen injectors with pen needles to inject prescription medicines. Health care providers who treat patients, or who train...

FDA Approves Toujeo (insulin glargine) Max SoloStar

BRIDGEWATER, N.J., March 27, 2018 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Sanofi's Toujeo (insulin glargine 300 Units/mL) Max SoloStar, the highest capacity long-acting...

FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes

KENILWORTH, N.J. & NEW YORK--(BUSINESS WIRE) December 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food...

FDA Approves Steglujan (ertugliflozin and sitagliptin) for Type 2 Diabetes

KENILWORTH, N.J. & NEW YORK--(BUSINESS WIRE) December 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes, Type 2, Diabetic Neuropathy, Diabetic Nerve Damage, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes

Related drug support groups

Tresiba, Levemir, insulin degludec